Semaglutide Linked to Age-Related Macular Degeneration Risk
Med Page Today
JUNE 5, 2025
(MedPage Today) -- Older adults taking GLP-1 receptor agonists, primarily semaglutide (Rybelsus, Ozempic, Wegovy), had a small uptick in their risk of developing neovascular age-related macular degeneration (nAMD), according to a retrospective.
Let's personalize your content